Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Crossover Study of Continuous Positive Airway Pressure (CPAP) Treatment Efficacy: Kairos PAP (KPAP) Versus Expiratory Pressure Relief (EPR)

NCT07530523 is registered in ClinicalTrials.gov with SleepRes Inc. as lead sponsor.

NCT NCT07530523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07530523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Crossover Study of Continuous Positive Airway Pressure (CPAP) Treatment Efficacy: Kairos PAP (KPAP) Versus Expiratory Pressure Relief (EPR)
Lead sponsor
SleepRes Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea